Lysophosphatidic acid inhibits serum deprivation-induced autophagy in human prostate cancer PC-3 cells

27Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Lysophosphatidic acid (LPA) is a platelet-enriched bioactive lysophospholipid. By binding to its cognitive G protein-coupled receptors, which are encoded by endothelial differentiation genes (edgs), LPA regulates various cellular activities including proliferation, survival, and migration. Currently, little is known about the influences of LPA on autophagy, a pivotal mechanism for cell survival during conditions of starvation. Herein we present data indicating that LPA attenuates starvation-induced autophagy, by monitoring the percentage of LC3-II, an autophagy indicator, in human prostate PC-3 cells. In addition, by using cells stably expressing EGFP-LC3, LPA is shown to inhibit the formation of autophagosomes in serum-starved conditions. Our results suggest that in these conditions, LPA inhibits autophagy, which might facilitate early cancer development. ©2007 Landes Bioscience.

Cite

CITATION STYLE

APA

Chang, C. L., Liao, J. J., Huang, W. P., & Lee, H. (2007). Lysophosphatidic acid inhibits serum deprivation-induced autophagy in human prostate cancer PC-3 cells. Autophagy, 3(3), 268–270. https://doi.org/10.4161/auto.3909

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free